Black Kale and Swiss Chard for Picky Eaters

Post date: 2022-06-30 10:39:29
Views: 107
I had a crazy week, lost track of the days and missed the deadline to customize (or cancel) my produce box. I have black kale and swiss chard and no idea what to do with them. I love green kale raw in salad, but the black kale doesn't seem like it would fit with that. And chard? I've made sauteed greens at various times but..

Steamed vegetables are not my thing. I will eat vegetables either raw or stir-fried mostly.

I eat green kale massaged and then as the green in salad. The black kale has a very different texture and I'm wondering if it will work there. I'm guessing it won't? Maybe I could chop it up very finely and sprinkle into a salad based on some other green? I do that with broccoleaf and like it. Any other ideas?

So you're going to say to sautee both the kale and the chard. I know you are. But everytime I sautee greens I totally miss the window and overcook them and they're slimy. And oh yeah, I need some soft of sauce to make them not bitter and preferably to make them a little sweet. But as soon as I add a liquid, we're back to being unable to control to sautee and ending up soggy and slimy.
Please click Here to read the full story.
 
Other Top and Latest Questions:
voice message by recording in question area
The Trump administration equity portfolio is growing. These are the investments so far
Nearly a thousand Google workers sign letter urging company to divest from ICE, CBP
The new Bilt 2.0 cards are open for application. Here's how to decide which card is right for you
Here are the 5 big things we're watching in the stock market this week
Trump’s 'big beautiful bill' may spur significant changes to higher education in 2026 and the rise of 'un-college,' experts say
Super Bowl 60: Movie trailers and AI dominate ads; Bad Bunny halftime ahead
Epstein files: UK PM Starmer's top aide McSweeney quits over Mandelson scandal
NFL plans to have discussions with partners outside of core media for live games, media chief says
Goldman Sachs says this under-the-radar biotech play could more than double in value